Cargando…

Systematic analysis of human oncogenic viruses in colon cancer revealed EBV latency in lymphoid infiltrates

BACKGROUND: Environmental factors may play a role in colon cancer. In this view, several studies investigated tumor samples for the presence of various viral DNA with conflicting results. FINDINGS: We undertook a systematic DNA analysis of 44 consecutive, prospectively collected primary tumor sample...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fiorina, Loretta, Ricotti, Mattia, Vanoli, Alessandro, Luinetti, Ombretta, Dallera, Elena, Riboni, Roberta, Paolucci, Stefania, Brugnatelli, Silvia, Paulli, Marco, Pedrazzoli, Paolo, Baldanti, Fausto, Perfetti, Vittorio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058445/ https://www.ncbi.nlm.nih.gov/pubmed/24936208 http://dx.doi.org/10.1186/1750-9378-9-18

Ejemplares similares

An overview of viral oncology in Italy - report from the Pavia meeting on solid tumors
por: Perfetti, Vittorio, et al.
Publicado: (2012)

EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count
por: Paolucci, Stefania, et al.
Publicado: (2021)

Small Bowel Carcinomas Associated with Immune-Mediated Intestinal Disorders: The Current Knowledge
por: Giuffrida, Paolo, et al.
Publicado: (2018)

The switch between EBV latency and replication.
por: Miller, G.
Publicado: (1989)

Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naïve patients
por: Paolucci, Stefania, et al.
Publicado: (2013)

EBV Latency Types Adopt Alternative Chromatin Conformations
por: Tempera, Italo, et al.
Publicado: (2011)

EBV-associated NK and T-cell lymphoid neoplasms
por: Kimura, Hiroshi, et al.
Publicado: (2022)

CTCF Prevents the Epigenetic Drift of EBV Latency Promoter Qp
por: Tempera, Italo, et al.
Publicado: (2010)

EBV Reactivation from Latency Is a Degrading Experience for the Host
por: Casco, Alejandro, et al.
Publicado: (2023)

Age-related EBV positive clonal B-cell Lymphoid proliferation (EBV+-DLBCL)
por: Georgakopoulou, Eleni, et al.
Publicado: (2017)

Oncogenic Properties of the EBV ZEBRA Protein
por: Germini, Diego, et al.
Publicado: (2020)

The Cooperative Functions of the EBNA3 Proteins Are Central to EBV Persistence and Latency
por: Styles, Christine T., et al.
Publicado: (2018)

Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients
por: Paolucci, Stefania, et al.
Publicado: (2012)

Detection and characterization of latency stage of EBV and histopathological analysis of prostatic adenocarcinoma tissues
por: Ahmed, Khalid, et al.
Publicado: (2022)

Mitochondrial protein, TBRG4, modulates KSHV and EBV reactivation from latency
por: Zhang, Huirong, et al.
Publicado: (2022)

The impact of HLA class I and EBV latency‐II antigen‐specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma
por: Jones, K., et al.
Publicado: (2015)

Small Bowel Adenocarcinomas Featuring Special AT-Rich Sequence-Binding Protein 2 (SATB2) Expression and a Colorectal Cancer-Like Immunophenotype: A Potential Diagnostic Pitfall
por: Neri, Giuseppe, et al.
Publicado: (2020)

Molecular and functional characterization of a new 3′ end KIT juxtamembrane deletion in a duodenal GIST treated with neoadjuvant Imatinib
por: Perfetti, Vittorio, et al.
Publicado: (2017)

A case of nodular lymphocyte predominant Hodgkin lymphoma with unexpected EBV-latency type
por: Rosenfeldt, Mathias T., et al.
Publicado: (2020)

The nuclear lamina binds the EBV genome during latency and regulates viral gene expression
por: Caruso, Lisa Beatrice, et al.
Publicado: (2022)

Long-lasting responses with chemotherapy followed by T-cell therapy in recurrent or metastatic EBV-related nasopharyngeal carcinoma
por: Secondino, Simona, et al.
Publicado: (2023)

Increase of Deep Intraepithelial Lymphocytes in the Oxyntic Mucosa of Patients With Potential and Overt Autoimmune Gastritis
por: Lenti, Marco Vincenzo, et al.
Publicado: (2022)

The Role of Codon Usage, tRNA Availability, and Cell Proliferation in EBV Latency and (Re)Activation
por: Kanduc, Darja
Publicado: (2022)

Unstable EBV latency drives inflammation in multiple sclerosis patient derived spontaneous B cells
por: Soldan, Samantha, et al.
Publicado: (2023)

Immunotherapeutic Intervention against Sarcomas
por: Pedrazzoli, Paolo, et al.
Publicado: (2011)

In vitro model for lytic replication, latency, and transformation of an oncogenic alphaherpesvirus
por: Schermuly, Julia, et al.
Publicado: (2015)

Nonsense-mediated decay controls the reactivation of the oncogenic herpesviruses EBV and KSHV
por: van Gent, Michiel, et al.
Publicado: (2021)

EBV(+) and MSI Gastric Cancers Harbor High PD-L1/PD-1 Expression and High CD8(+) Intratumoral Lymphocytes
por: De Rosa, Simona, et al.
Publicado: (2018)

New insights into the role of age and carcinoembryonic antigen in the prognosis of colorectal cancer
por: Gobbi, P G, et al.
Publicado: (2008)

EBV-associated lymphoid interstitial pneumonia in IBD patient: Case report and literature review
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2020)

Effectiveness of the available early therapies in reducing severe COVID-19 in non-hospitalized patients with solid tumors on active treatment
por: Lasagna, Angioletta, et al.
Publicado: (2022)

Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: A real-life retrospective single-center cohort study
por: Lasagna, Angioletta, et al.
Publicado: (2023)

EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency
por: Styles, Christine T., et al.
Publicado: (2017)

A Metachronous splenic metastases from esophageal cancer: a case report
por: Botrugno, Ivan, et al.
Publicado: (2011)

Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay
por: Cassaniti, Irene, et al.
Publicado: (2019)

Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers
por: Li, Boheng, et al.
Publicado: (2021)

Treatment with a BH3 mimetic overcomes the resistance of latency III EBV (+) cells to p53-mediated apoptosis
por: Pujals, A, et al.
Publicado: (2011)

EBV genome carrying B lymphocytes that express the nuclear protein EBNA-2 but not LMP-1: Type IIb latency
por: Klein, Eva, et al.
Publicado: (2013)

A comprehensive single cell data analysis of lymphoblastoid cells reveals the role of super‐enhancers in maintaining EBV latency
por: Yan, Bingyu, et al.
Publicado: (2022)

EBV persistence without its EBNA3A and 3C oncogenes in vivo
por: Murer, Anita, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_29jcftmqc31o5iag23dltmikjb